{
    "d00a1c92-49ee-35ec-b174-f6d2942747ab": {
        "uuid": "d00a1c92-49ee-35ec-b174-f6d2942747ab",
        "title": "AbbVie Presents Positive Data from Phase 3 Study of Cariprazine (VRAYLAR\u00ae) for the Adjunctive Treatment of Major Depressive Disorder at 2022 APA Annual Meeting",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/abbvie-presents-positive-data-phase-120000832.html",
        "providerPublishTime": 1653307200,
        "type": "STORY"
    },
    "4ff7ae82-638d-394c-8f4a-2120b7307f76": {
        "uuid": "4ff7ae82-638d-394c-8f4a-2120b7307f76",
        "title": "CHMP Recommends European Commission Approval of Upadacitinib (RINVOQ\u00ae) for the Treatment of Adults with Moderate to Severe Ulcerative Colitis",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/chmp-recommends-european-commission-approval-060000276.html",
        "providerPublishTime": 1653285600,
        "type": "STORY"
    },
    "4ae7afff-bf00-3983-b96a-1128a80c252a": {
        "uuid": "4ae7afff-bf00-3983-b96a-1128a80c252a",
        "title": "7 Retirement Stocks to Buy for Any Market Conditions",
        "publisher": "InvestorPlace",
        "link": "https://finance.yahoo.com/news/7-retirement-stocks-buy-market-113140782.html",
        "providerPublishTime": 1653132700,
        "type": "STORY"
    },
    "c63d5b9a-ec62-35af-9e99-861e3632fb27": {
        "uuid": "c63d5b9a-ec62-35af-9e99-861e3632fb27",
        "title": "Warren Buffett is Selling These 6 Stocks in 2022",
        "publisher": "Insider Monkey",
        "link": "https://finance.yahoo.com/news/warren-buffett-selling-6-stocks-131707882.html",
        "providerPublishTime": 1653052627,
        "type": "STORY"
    },
    "21389253-7f86-3b68-a7e0-4913ce20047f": {
        "uuid": "21389253-7f86-3b68-a7e0-4913ce20047f",
        "title": "Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/investors-heavily-search-abbvie-inc-130001244.html",
        "providerPublishTime": 1653051601,
        "type": "STORY"
    },
    "ac8e07b8-3689-3f54-a1c7-a17ceb79d2b8": {
        "uuid": "ac8e07b8-3689-3f54-a1c7-a17ceb79d2b8",
        "title": "Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's Tirzepatide",
        "publisher": "Zacks",
        "link": "https://finance.yahoo.com/news/pharma-stock-roundup-fda-nod-125012943.html",
        "providerPublishTime": 1653051012,
        "type": "STORY"
    },
    "7cc50f27-b951-3bc2-8453-e82ffa22e733": {
        "uuid": "7cc50f27-b951-3bc2-8453-e82ffa22e733",
        "title": "AbbVie Submits New Drug Application to U.S. FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa) for the Treatment of Advanced Parkinson's Disease",
        "publisher": "PR Newswire",
        "link": "https://finance.yahoo.com/news/abbvie-submits-drug-application-u-121500454.html",
        "providerPublishTime": 1653048900,
        "type": "STORY"
    },
    "4569f40d-c411-36c8-83a8-8b533f2b013d": {
        "uuid": "4569f40d-c411-36c8-83a8-8b533f2b013d",
        "title": "6 Stocks to Buy to Hedge Your Portfolio in a Down Market",
        "publisher": "InvestorPlace",
        "link": "https://finance.yahoo.com/news/6-stocks-buy-hedge-portfolio-160044938.html",
        "providerPublishTime": 1652976044,
        "type": "STORY"
    }
}